1. Home
  2. PHGE vs EDUC Comparison

PHGE vs EDUC Comparison

Compare PHGE & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • EDUC
  • Stock Information
  • Founded
  • PHGE 2015
  • EDUC 1965
  • Country
  • PHGE Israel
  • EDUC United States
  • Employees
  • PHGE N/A
  • EDUC N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • EDUC Consumer Specialties
  • Sector
  • PHGE Health Care
  • EDUC Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • EDUC Nasdaq
  • Market Cap
  • PHGE 13.3M
  • EDUC 10.1M
  • IPO Year
  • PHGE N/A
  • EDUC N/A
  • Fundamental
  • Price
  • PHGE $0.56
  • EDUC $1.30
  • Analyst Decision
  • PHGE Strong Buy
  • EDUC
  • Analyst Count
  • PHGE 2
  • EDUC 0
  • Target Price
  • PHGE $23.00
  • EDUC N/A
  • AVG Volume (30 Days)
  • PHGE 51.4K
  • EDUC 9.7K
  • Earning Date
  • PHGE 05-15-2025
  • EDUC 05-21-2025
  • Dividend Yield
  • PHGE N/A
  • EDUC N/A
  • EPS Growth
  • PHGE N/A
  • EDUC N/A
  • EPS
  • PHGE N/A
  • EDUC N/A
  • Revenue
  • PHGE N/A
  • EDUC $36,523,200.00
  • Revenue This Year
  • PHGE N/A
  • EDUC N/A
  • Revenue Next Year
  • PHGE N/A
  • EDUC N/A
  • P/E Ratio
  • PHGE N/A
  • EDUC N/A
  • Revenue Growth
  • PHGE N/A
  • EDUC N/A
  • 52 Week Low
  • PHGE $0.48
  • EDUC $0.92
  • 52 Week High
  • PHGE $4.99
  • EDUC $2.49
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 44.80
  • EDUC 54.48
  • Support Level
  • PHGE $0.54
  • EDUC $1.22
  • Resistance Level
  • PHGE $0.58
  • EDUC $1.59
  • Average True Range (ATR)
  • PHGE 0.04
  • EDUC 0.13
  • MACD
  • PHGE 0.00
  • EDUC 0.01
  • Stochastic Oscillator
  • PHGE 32.83
  • EDUC 30.95

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

Share on Social Networks: